Treatment Registry
TR-1028 ActiveRecorded October 2026

Compounded tirzepatide

Sold by Evolve Telemed · Injection · device not recorded · every compounded tirzepatide record

The program identifies an injection, but the delivery device has not been established.

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Visit Evolve Telemed

We earn nothing from this link. It opens Evolve Telemed's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • October 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberNot disclosed
CancellationMedication sales are non-refundable and non-returnable. The annual care plan is non-refundable after the initial physician consultation. https://evolvetelemed.com/terms-conditions/
MembershipConditional (For patients enrolled in the annual care plan). Amount not published. The annual care plan covers an initial physician consultation and physician-requested follow-ups. The terms do not publish its price. https://evolvetelemed.com/terms-conditions/
Consult feeNot disclosed

Recorded from evolvetelemed.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — Evolve offers an online prescription pathway for tirzepatide and describes weekly subcutaneous injections. Its medication terms state that all medications are compounded specifically for the patient. The product page lists niacinamide among the ingredients. The dispensing device and named pharmacy are not specified. https://evolvetelemed.com/treatments/tirzepatide/ https://evolvetelemed.com/terms-conditions/
  2. 2. October 2026 — The product page does not publish a medication price or a payable treatment total. The annual care plan and its clinical consultation should not be confused with the free introductory consultation offer. https://evolvetelemed.com/treatments/tirzepatide/ https://evolvetelemed.com/terms-conditions/
  3. 3. October 2026 — General telehealth terms list service jurisdictions and require the patient to be in a jurisdiction where the clinician is licensed. That list does not establish availability of every formulation in every state. https://evolvetelemed.com/terms-conditions/
  4. 4. October 2026 — The annual care plan includes physician consultations for enrolled patients. The reviewed pages do not establish a separate clinical consultation fee or that annual enrollment is required for every medication order. A free introductory consultation is advertised. https://evolvetelemed.com/terms-conditions/

2 further notes concern other Evolve Telemed programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1028
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Evolve Telemed — compounded tirzepatide (TR-1028). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1028

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.